Abstract
Rieckmann, P, Centonze, D, Giovannoni, G, et al. Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice. Ther Adv Neurol Disord 2021; 14:1–13. DOI: 10.1177/17562864211058298
There is an error in Table 2. The percentage in Q4, CR8 is 91.7%. Also the text in the table should read “N=33/36” instead of “N=33/38”.